Cargando…
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Autores principales: | Eskiocak, Ugur, Ramesh, Vijayashree, Gill, Jennifer G., Zhao, Zhiyu, Yuan, Stacy W., Wang, Meng, Vandergriff, Travis, Shackleton, Mark, Quintana, Elsa, Frankel, Arthur E., Johnson, Timothy M., DeBerardinis, Ralph J., Morrison, Sean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056410/ https://www.ncbi.nlm.nih.gov/pubmed/27681157 http://dx.doi.org/10.1038/ncomms13080 |
Ejemplares similares
-
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
por: Eskiocak, Ugur, et al.
Publicado: (2016) -
Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients
por: Frankel, Arthur E., et al.
Publicado: (2017) -
Metabolic heterogeneity confers differences in melanoma metastatic potential
por: Tasdogan, Alpaslan, et al.
Publicado: (2019) -
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis
por: Shelton, Spencer D., et al.
Publicado: (2023) -
Erratum to: Synergistic anti-malarial action of cryptolepine and artemisinins
por: Forkuo, Arnold D., et al.
Publicado: (2016)